Published in Surgery Litigation and Law Weekly, June 8th, 2007
Study 1: Scientists discuss in "Asymmetrical dimethylarginine (ADMA) and coronary endothelial function in patients with coronary artery disease and mild hypercholesterolemia" new findings in heart disease. In this recent report published in the journal Atherosclerosis, researchers in Hamburg, Germany conducted a study "To investigate the association of the endogenous nitric oxide synthase inhibitor asymmetrical dimethylarginine (ADMA) and coronary endothelial function. In 289 patients with coronary artery disease we assessed coronary endothelium-dependent and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Surgery Litigation and Law Weekly